SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-214315
Filing Date
2013-05-10
Accepted
2013-05-10 16:32:25
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d508928d10q.htm 10-Q 472961
2 EX-31.1 d508928dex311.htm EX-31.1 10113
3 EX-31.2 d508928dex312.htm EX-31.2 10329
4 EX-32.1 d508928dex321.htm EX-32.1 5178
  Complete submission text file 0001193125-13-214315.txt   4496151

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aria-20130331.xml EX-101.INS 569178
6 XBRL TAXONOMY EXTENSION SCHEMA aria-20130331.xsd EX-101.SCH 48337
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aria-20130331_cal.xml EX-101.CAL 68635
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aria-20130331_def.xml EX-101.DEF 283574
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aria-20130331_lab.xml EX-101.LAB 377442
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aria-20130331_pre.xml EX-101.PRE 339109
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21696 | Film No.: 13833935
SIC: 2836 Biological Products, (No Diagnostic Substances)